{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:11:10Z","timestamp":1772507470581,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.74962","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:30:36Z","timestamp":1733142636000},"source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune Hepatitis and Systemic Lupus Erythematosus Overlap Syndrome: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Maryam A","family":"Kheyami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatin R","family":"Almahroos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa M","family":"Alzamrooni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Khamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Albaharna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis","volume":"65","author":"Hahn JW","year":"2023","unstructured":"Hahn JW, Yang HR, Moon JS, et al.. Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis. EClinicalMedicine. 2023, 65:102280. 10.1016\/j.eclinm.2023.102280","journal-title":"EClinicalMedicine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000440707","article-title":"Association of extrahepatic manifestations with autoimmune hepatitis","volume":"33 Suppl 2","author":"Wong GW","year":"2015","unstructured":"Wong GW, Heneghan MA. Association of extrahepatic manifestations with autoimmune hepatitis. Dig Dis. 2015, 33 Suppl 2:25-35. 10.1159\/000440707","journal-title":"Dig Dis"},{"key":"ref3","article-title":"Overview of autoimmune hepatitis","author":"Heneghan M","year":"2023","unstructured":"Heneghan M. Overview of autoimmune hepatitis. UpToDate. Connor R, Chopra S, Robson K (ed): Wolters Kluwer, Massachusetts; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian J","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023, 82:351-6. 10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"ref5","article-title":"Clinical manifestations and diagnosis of systemic lupus erythematosus in adults","author":"Wallace D","year":"2023","unstructured":"Wallace D, Gladman D. Clinical manifestations and diagnosis of systemic lupus erythematosus in adults. UpToDate. Connor R, Pisetsky D, Case S (ed): Wolters Kluwer, Massachusetts; 2023."},{"key":"ref6","article-title":"Gastrointestinal manifestations of systemic lupus erythematosus","author":"Massarotti E","year":"2023","unstructured":"Massarotti E. Gastrointestinal manifestations of systemic lupus erythematosus. UpToDate. Connor R, Pisetsky D, Case S, Robson K (ed): Wolters Kluwer, Massachusetts; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90378-2","article-title":"The spectrum of liver disease in systemic lupus erythematosus- report of 33 histologically-proved cases and review of the literature","volume":"69","author":"Runyon BA","year":"1980","unstructured":"Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus- report of 33 histologically-proved cases and review of the literature. Am J Med. 1980, 69:187-94. 10.1016\/0002-9343(80)90378-2","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak K","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, et al.. Histological grading and staging of chronic hepatitis. J Hepatol. 1995, 22:696-9. 10.1016\/0168-8278(95)80226-6","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740986","article-title":"The ototoxicity of chloroquine and hydroxychloroquine: a systematic review","volume":"26","author":"Fernandes CP","year":"2022","unstructured":"Fernandes CP, Vernier LS, Dallegrave E, Machado MS. The ototoxicity of chloroquine and hydroxychloroquine: a systematic review. Int Arch Otorhinolaryngol. 2022, 26:e167-77. 10.1055\/s-0041-1740986","journal-title":"Int Arch Otorhinolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes EM","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al.. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008, 48:169-76. 10.1002\/hep.22322","journal-title":"Hepatology"},{"key":"ref11","article-title":"Management of autoimmune hepatitis","author":"Heneghan M","year":"2024","unstructured":"Heneghan M. Management of autoimmune hepatitis. UpToDate. Connor R, Chopra S, Rand EB, Robson KM (ed): Wolters Kluwer, Massachusetts; 2024."},{"key":"ref12","article-title":"Systemic lupus erythematosus in adults: overview of the management and prognosis","author":"Wallace D","year":"2024","unstructured":"Wallace D. Systemic lupus erythematosus in adults: overview of the management and prognosis. UpToDate. Connor R, Pisetsky D, Rigby W, Case S (ed): Wolters Kluwer, Massachusetts; 2024."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/C2017-0-00241-0","article-title":"Scheuer's liver biopsy interpretation","author":"Lefkowitch J","year":"2020","unstructured":"Lefkowitch J. Scheuer's liver biopsy interpretation. Elsevier, Amsterdam; 2020. 10.1016\/C2017-0-00241-0"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v6.i6.394","article-title":"Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis","volume":"6","author":"Bessone F","year":"2014","unstructured":"Bessone F, Poles N, Roma MG. Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis. World J Hepatol. 2014, 6:394-409. 10.4254\/wjh.v6.i6.394","journal-title":"World J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.15-3-244","article-title":"Blood alanine aminotransferase levels &gt;1,000 IU\/l - causes and outcomes","volume":"15","author":"Galvin Z","year":"2015","unstructured":"Galvin Z, McDonough A, Ryan J, Stewart S. Blood alanine aminotransferase levels &amp;gt;1,000 IU\/l - causes and outcomes. Clin Med (Lond). 2015, 15:244-7. 10.7861\/clinmedicine.15-3-244","journal-title":"Clin Med (Lond)"},{"key":"ref16","unstructured":"Centers for Disease Control and Prevention. clinical overview of viral hepatitis. (2024). Accessed: October 15, 2024: https:\/\/www.cdc.gov\/hepatitis\/hcp\/clinical-overview\/index.html."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200012)43:12<2801::AID-ANR21>3.0.CO;2-V","article-title":"Hepatitis C virus infection mimicking systemic lupus erythematosus- study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus","volume":"43","author":"Ramos-Casals M","year":"2000","unstructured":"Ramos-Casals M, Font J, Garcia-Carrasco M, et al.. Hepatitis C virus infection mimicking systemic lupus erythematosus- study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum. 2000, 43:2801-6. 10.1002\/1529-0131(200012)43:12&lt;2801::AID-ANR21&gt;3.0.CO;2-V","journal-title":"Arthritis Rheum"},{"key":"ref18","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos P","year":"2009","unstructured":"Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009, 13:9-19.","journal-title":"Hippokratia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(88)80022-2","article-title":"Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis","volume":"95","author":"Williams AL","year":"1988","unstructured":"Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology. 1988, 95:734-9. 10.1016\/s0016-5085(88)80022-2","journal-title":"Gastroenterology"},{"key":"ref20","article-title":"Clinical manifestations of antiphospholipid syndrome","author":"Erkan D","year":"2024","unstructured":"Erkan D, Zuily S. Clinical manifestations of antiphospholipid syndrome. UpToDate. Connor R, Pisetsky D, Case S, Tirnauer J (ed): Wolters Kluwer, Massachusetts; 2024."},{"key":"ref21","article-title":"Primary sclerosing cholangitis in adults: clinical manifestations and diagnosis","author":"Kowdley K","year":"2023","unstructured":"Kowdley K. Primary sclerosing cholangitis in adults: clinical manifestations and diagnosis. UpToDate. Connor R, Lindor K, Robson K (ed): Wolters Kluwer, Massachusetts; 2023."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-31696-5.00055-3","article-title":"Anti-nuclear antibodies","author":"Peng S","year":"2017","unstructured":"Peng S, Craft J. Anti-nuclear antibodies. Kelley and Firestein's Textbook of Rheumatology (10th edition). Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR (ed): Elsevier, Amsterdam; 2017. 1:817-30. 10.1016\/B978-0-323-31696-5.00055-3"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.940478","article-title":"Co-presentation of lupus nephritis with autoimmune hepatitis","volume":"24","author":"Chaudhary FS","year":"2023","unstructured":"Chaudhary FS, Sureen A, Yousaf MN, Rao DS, Siva C. Co-presentation of lupus nephritis with autoimmune hepatitis. Am J Case Rep. 2023, 24:e940478. 10.12659\/AJCR.940478","journal-title":"Am J Case Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.558114","article-title":"Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases","volume":"46","author":"Efe C","year":"2011","unstructured":"Efe C, Purnak T, Ozaslan E, et al.. Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol. 2011, 46:732-7. 10.3109\/00365521.2011.558114","journal-title":"Scand J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i35.12662","article-title":"Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature","volume":"20","author":"Beisel C","year":"2014","unstructured":"Beisel C, Weiler-Normann C, Teufel A, Lohse AW. Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature. World J Gastroenterol. 2014, 20:12662-7. 10.3748\/wjg.v20.i35.12662","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1275","article-title":"Chloroquine is effective for maintenance of remission in autoimmune hepatitis: Controlled, double-blind, randomized trial","volume":"3","author":"Raquel Benedita Terrabuio D","year":"2019","unstructured":"Raquel Benedita Terrabuio D, Augusto Diniz M, Teofilo de Moraes Falc\u00e3o L, et al.. Chloroquine is effective for maintenance of remission in autoimmune hepatitis: Controlled, double-blind, randomized trial. Hepatol Commun. 2019, 3:116-28. 10.1002\/hep4.1275","journal-title":"Hepatol Commun"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15970","article-title":"Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry","volume":"44","author":"Riveiro-Barciela M","year":"2024","unstructured":"Riveiro-Barciela M, Barreira-D\u00edaz A, Esteban P, et al.. Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry. Liver Int. 2024, 44:2303-14. 10.1111\/liv.15970","journal-title":"Liver Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100123","article-title":"Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis","volume":"2","author":"Arvaniti P","year":"2020","unstructured":"Arvaniti P, Giannoulis G, Gabeta S, Zachou K, Koukoulis GK, Dalekos GN. Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis. JHEP Rep. 2020, 2:100123. 10.1016\/j.jhepr.2020.100123","journal-title":"JHEP Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.04.002","article-title":"Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review","volume":"44","author":"Cobo-Ib\u00e1\u00f1ez T","year":"2014","unstructured":"Cobo-Ib\u00e1\u00f1ez T, Loza-Santamar\u00eda E, Pego-Reigosa JM, et al.. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2014, 44:175-85. 10.1016\/j.semarthrit.2014.04.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010668.pub2","article-title":"Belimumab for systemic lupus erythematosus","volume":"2","author":"Singh JA","year":"2021","unstructured":"Singh JA, Shah NP, Mudano AS. Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021, 2:CD010668. 10.1002\/14651858.CD010668.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316940-autoimmune-hepatitis-and-systemic-lupus-erythematosus-overlap-syndrome-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:30:40Z","timestamp":1733142640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316940-autoimmune-hepatitis-and-systemic-lupus-erythematosus-overlap-syndrome-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.74962","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}